A Multi-centre, Double-blind, Double-dummy, Placebo Controlled Parallel Group Randomized Phase IIb Proof of Concept Study With 3 Oral Dose Groups of AZD3480 or Donepezil During 12 Weeks Treatment in Patients With Alzheimer's Disease
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2014
At a glance
- Drugs Ispronicline (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms SIROCCO
- 12 Jul 2009 Results have been presented at ICAD 2009.
- 20 May 2009 Additional lead trial centre identified as reported by United Kingdom Clinical Research Network.
- 26 Feb 2009 New source identified and integrated (United Kingdom Clinical Research Network registry record).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History